Semaglutide for the treatment of type 2 diabetes mellitus: a systematic review and network meta-analysis of safety and efficacy outcomes

MS Zaazouee, A Hamdallah, SK Helmy… - Diabetes & Metabolic …, 2022 - Elsevier
Background and aims To assess the safety and efficacy of semaglutide compared with
placebo and other anti-hyperglycaemic agents in type 2 diabetes (T2DM). Methods We …
被引用次数：30 相关文章

Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes

MS Zaazouee, A Hamdallah, SK Helmy… - Diabetes & Metabolic …, 2022 - Elsevier
Background and aims To assess the safety and efficacy of semaglutide compared with
placebo and other anti-hyperglycaemic agents in type 2 diabetes (T2DM). Methods We …

Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes

MS Zaazouee, A Hamdallah… - Diabetes & …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and aims To assess the safety and efficacy of semaglutide compared with
placebo and other anti-hyperglycaemic agents in type 2 diabetes (T2DM). Methods We …

Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes.

MS Zaazouee, A Hamdallah, SK Helmy… - Diabetes & Metabolic …, 2022 - europepmc.org
Methods We searched PubMed, Scopus, Web of Science, and Cochrane library for relevant
randomized controlled trials (RCTs). A network meta-analysis was conducted to compare …